Skip to main content

Table 3 First recurrence (r1) after endoscopic nasopharyngectomy

From: 5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma

Patient # Location of first recurrence r1TNM / r1Stage Time to second recurrence (months) Subsequent treatment Surgical margins Adjunctive therapy
P1 Nasopharynx, posterior inferior turbinate T1N0M0 / Stage 1 24.6 Endoscopic nasopharyngectomy, partial medial maxillectomy none
P2 Fossa of Rossenmuller T1N0M0 / Stage 1 5.6 Endoscopic nasopharyngectomy none
P4 Parapharyngeal space (carotid extension) T2N0M0 / Stage 2 34.5 Chemo via docetaxel and cisplatin (currently alive with stable disease) N/A N/A
P8 Nasopharynx; pterygomaxillary fossa; infratemporal fossa T4N0M0 / Stage 4 25.2 Endoscopic nasopharyngectomy, dissection of pterygomaxillary fossa, dissection of infratemporal fossa + (infratemporal fossa) CyberKnife SRT (1.6Gy)
P10 Parapharyngeal space (carotid extension), skullbase, bilateral retropharyngeal nodes T3N2M0 / Stage 3 14.4 Chemo via docetaxel and cetuximab (currently alive in comfort care) N/A N/A
P11 Sphenoid sinus; pterygopalatine fossa T3N0M0 / Stage 3 9 Sphenoidotomy; pterygopalatine fossa dissection None